Drug Development market research reports by GlobalData

• Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research

  Jun 30, 2022  |  Published by: GlobalData  |  USD 1,950

  Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research Summary The Genomics Landscape Continues to Be Dynamic in Q2 2022 With Less Activity Seen in Immuno-oncology. The genomics landscape was active in Q2 2022, with scores increased for several companies. This includes ... Read More

• Artificial Intelligence (AI) in Drug Discovery - Thematic Research

  Jun 28, 2022  |  Published by: GlobalData  |  USD 1,950

  Artificial Intelligence (AI) in Drug Discovery - Thematic Research Summary In recent years, driven by the COVID-19 pandemic, the pharma industry has undergone increased levels of digital transformation. The availability of ultra-large datasets and technological advances has led to more interest in t ... Read More

• Clinical Trials - Where are we Headed with COVID-19 Trials?

  May 24, 2022  |  Published by: GlobalData  |  USD 695

  Clinical Trials - Where are we Headed with COVID-19 Trials? Summary This report provides an overview of global COVID-19 clinical trials extracted from the GlobalData Pharma Intelligence Center on March 30, 2022. The purpose of this report is to provide insight into the overall clinical trial landsca ... Read More

• Neuroimmunology Drug Development - Thematic Research

  Apr 22, 2022  |  Published by: GlobalData  |  USD 7,995

  Neuroimmunology Drug Development - Thematic Research Summary This report provides an overview of neuroimmunology drug development within eight key indications across eight pharmaceutical markets. The neuroimmune system is complex and a critical component in regulating nervous system health and disea ... Read More

• Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022

  Mar 07, 2022  |  Published by: GlobalData  |  USD 2,495

  Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022 Summary When faced with an outbreak of a pathogen with no known treatments, we are forced to rely on the pharmaceutical industry to develop interventions to curb these potential disasters. The COVID-19 Clinical and Com ... Read More

• Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026

  Mar 03, 2022  |  Published by: GlobalData  |  USD 3,495

  Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026 Summary In gastroparesis Dopamine (D2) receptor is a major focus of drug developers. There are 17 drugs in the pipeline with 90% molecules present in early stage. Mid-sized Pharma ... Read More

< prev 1 2 next >